Want to read Slashdot from your mobile device? Point it at m.slashdot.org and keep reading!

 


Forgot your password?
Close
typodupeerror
×
The Internet

Submission + - Livejournal under Russian DDOS

Submitted by
Tom Womack
Tom Womack writes: "Over the last 24 hours, people have been noticing that no packet containing the character sequence DPNI is getting through to livejournal.com. Livejournal have announced that this is a side-effect of blocking a DDOS against them, presumably (DPNI being a Russian anti-immigrant party) by Russian interests."

Feed Google acquires Panoramio (theregister.com)

From feed by registerfeed
Adds photo-sharing to its panoply of services

Google continued its attempts to offer every service imaginable online by purchasing a Spanish photo-sharing website.
Intel

Intel's Penryn Benchmarked 124

Posted by CmdrTaco from the slightly-faster-than-my-286 dept.
Steve Kerrison writes "Intel's keen to show off its up-coming 45nm Penryn Core 2 CPU. HEXUS had some hands on time with the new processor to get an idea of how well it will perform once its released: 'Intel's new 45nm Penryn core adds more than just a clock and FSB hike, so much so that even a dual-core Penryn is able to beat out a quad-core QX6800 under certain circumstances.'"

FDA Gets Mixed Advice on Nanotechnology 54

Posted by samzenpus from the better-living-through-small-machines dept.
mikesd81 writes, "There's an article at the Associated Press about how the government must balance close oversight of the fast-growing field of nanotechnology against the risk of stifling new development. Contrasting view came from a panel of experts brought together to discuss how nanotechnology should be regulated. The article states that submicroscopic particles are being incorporated in the thousands of products overseen by the FDA, including drugs, foods, cosmetics and medical devices and the products consist of roughly 20% of each dollar spent by U.S. consumers. Matthew Jaffe of the U.S. Council of International Business says, "The key is to use science to weigh both the benefits and the risks of nanotechnology. That's a balance the FDA already seeks to strike in assessing other products." From the article: "'The success of nanotechnology will rely in large part on how FDA plays its regulatory role,' said Michael Taylor of the University of Maryland's School of Public Health. The FDA doesn't believe nanotechnology is inherently unsafe, but does acknowledge that materials at the nano scale can pose different safety issues than do things that are far larger. 'The FDA wants to learn of new and emerging science issues related to nanotechnology, especially in regard to safety,' said Randall Lutter, the agency's associate commissioner."

Slashdot Top Deals

"It says he made us all to be just like him. So if we're dumb, then god is dumb, and maybe even a little ugly on the side." -- Frank Zappa

Close